# Certara Inc. (CERT) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $7.94, market value $1.2 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Certara Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 0.23**. A PEG of 0.23 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 3.0×**. Each dollar of revenue is priced at 3.0×.
- **Price / book: 1.3×**. The shares trade at 1.3× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 18.9×**. Enterprise value is 18.9× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 6.6%** (5-yr avg 3.8%). Free cash flow equals 6.6% of the market value, above its five-year average of 3.8%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.

## Profitability
- **Operating margin: -0.2%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -0.4%**. The company reported a net loss over the last twelve months.
- **Return on equity: -0.2%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -0.0%**. Return on all capital, debt included, is -0.0%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -4.4%**. Each dollar of assets produces -4.4% of profit.

## Growth
- **Revenue growth (1 yr): 8.7%** (3-yr 7.7%/yr, 5-yr 11.5%/yr). Revenue grew 8.7% over the last year, against 11.5% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 87.5%**. Earnings per share rose 87.5%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): 1.2%/yr**. Free cash flow has compounded at 1.2% a year over three years.

## Financial health
- **Debt to equity: 0.28**. Debt is 0.28 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 1.5×**. It would take 1.5 years of operating earnings to repay net borrowings, within the comfortable range.
- **Altman Z-score: 2.74**. A Z-score of 2.74 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Certara Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): -25.0%** (YTD -9.9%, 3-mo 47.9%). The shares are down 25.0% over twelve months including dividends.
- **From 52-week high: -42.8%** (78.4% above the low). Trading 43% below its 52-week high, deep in a drawdown.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 49**. An RSI of 49 is neutral.
- **Beta (1 yr): 0.80** (volatility 60%). Beta of 0.80 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CERT · Page: https://foliofundamentals.com/stocks/cert

Not investment advice.